1. Home
  2. Research and Funding
  3. Current Funding Opportunities
  4. Limited Competition for the Continuation of the Intestinal Stem Cell Consortium Research Centers (U01 Clinical Trial Not Allowed)

Limited Competition for the Continuation of the Intestinal Stem Cell Consortium Research Centers (U01 Clinical Trial Not Allowed)

This Limited Competition Funding Opportunity Announcement (FOA) invites applications from the Program Directors/Principal Investigators of the nine current Research Centers (RCs) of the Intestinal Stem Cell Consortium (ISCC) to submit collaborative projects to characterize the minimal, required niche factors that support intestinal stem cells in health and disease, using an integrated, multidisciplinary team science approach. The nine current RCs have been collaborating for the past 4 years, answering major questions in stem cell biology of the intestinal epithelium and also accelerating research by making information and resources available to the research community. In addition, the RCs have established effective and proficient collaborations with other RCs within the ISCC. The primary objective of this FOA is to continue advancing the understanding of intestinal epithelial stem cell biology with the ultimate goal of developing novel therapies targeting intestinal stem cells and supportive niche to regenerate and rebuild the human intestine.

Funding Opportunity Details

RFA-DK-18-507
None

Patricia Greenwel, Ph.D.

Key Dates

10/21/2018

October 21, 2018

November 21, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity are due on this date. No late applications will be accepted for this Funding Opportunity Announcement.

Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.